Thursday, 23 May 2019

Esperoct (turoctocog alfa pegol) for the Treatment of Haemophilia A, USA - Drug Development Technology

Esperoct (turoctocog alfa pegol) for the Treatment of Haemophilia A, USA  Drug Development Technology

Esperoct® (turoctocog alfa pegol) is a recombinant anti-haemophilic factor indicated for the treatment of haemophilia A in adults and children.

No comments:

Post a Comment